SciNeuro
Business Services · Maryland, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
9808 Medical Center Dr Ste 470, Rockvill...Website
www.scineuro.comRevenue
$7.4 MillionIndustry
About SciNeuro
SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration neurovascular inflammation, proteinopathy, and immune response. The company aims to develop disease-modifying treatment options for Alzheimer's disease, Parkinson's disease, and other devastating CNS diseases.Explore more
SciNeuro Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to SciNeuro
Compare insights from companies similar to SciNeuro, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
SciNeuro Tech Stack
A closer look at the technologies used by SciNeuro
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding SciNeuro
Sign Up For FreeTo access detailed company insights
SciNeuro Pharmaceuticals is a clinical-stage biotechnology company focused on developing groundbreaking therapies for neurodegenerative diseases. Since its founding in 2020, SciNeuro has built a portfolio of pipeline programs staged from discovery to clinical development by addressing three key disease-driving mechanisms of neurodegeneration neurov... Read More
